Theater Titan's Bold Bid: David Ellison Guarantees Paramount-WB's 30-Film Slate to Cinemas!

David Ellison, the ambitious CEO of Paramount Skydance, is making a strong case for the proposed merger with Warner Bros. Discovery, a deal notable for its eye-popping price. A central pillar of Ellison's pitch, both during his initial hostile takeover bid and subsequent negotiations, has been a steadfast pledge that the combined entity would significantly increase cinematic output, aiming for at least 30 new theatrical titles per year. This commitment to higher volume is presented as a crucial step to revitalize the movie business.

To solidify this promise, Ellison is reportedly offering three-year, contractually enforceable commitments to the United States' largest theater chains, AMC Entertainment and Regal Cinemas. These agreements would guarantee exclusive 45-day theatrical windows for their releases and a moratorium on distributing these films on streaming services for a minimum of 90 days, with potential financial penalties if Paramount fails to uphold its end of the bargain. This proactive measure has garnered strong public support from the CEOs of both AMC and Regal, and Paramount has publicly affirmed its willingness to formalize the 30-movie commitment in writing.

This commitment is also strategically designed to address a significant challenge: an antitrust lawsuit filed by 12 state attorneys general. The lawsuit alleges that a merged Paramount-Warner Bros. would exert excessive control over the market for theatrical releases. By guaranteeing a substantial number of new releases and traditional windowing, Ellison aims to position the merged company as a contributor to market vibrancy rather than a monopolist. While a trial in this case is scheduled for March 2027, Ellison is under pressure to reach an out-of-court settlement. However, it remains uncertain whether the 30-title/45-day window guarantee will be a sufficient concession for the state attorneys general, especially given that it does not address another key allegation concerning the merged entity's potential excessive power in the U.S. basic cable TV market.

Despite the strong emphasis on quantity, a fundamental question remains regarding the efficacy of this strategy: what if a majority of these 30 promised movies are commercial disappointments or niche titles with limited appeal? In a recent New York Times op-ed, Ellison candidly admitted the impossibility of guaranteeing the financial success of any given theatrical release. Citing examples like "G.I. Joe: Retaliation," "Top Gun: Maverick," and "Terminator: Dark Fate," he stated, "What I can promise is the work, and more of it." This perspective highlights a crucial point: simply increasing the number of films does not inherently translate to greater financial returns for the industry or the studio itself.

Indeed, Paramount's own recent performance illustrates this challenge. The studio's 2025 film slate nearly doubled from eight films to fifteen, yet Paramount informed Wall Street that it anticipates "significantly lower theatrical revenue year-over-year due to lower average box office revenue per film across more releases." This projected decline is largely attributed to a tough year-over-year comparison with blockbusters like Tom Cruise’s "Mission: Impossible – The Final Reckoning" from 2025, which amassed nearly $600 million globally. In the second quarter of 2026, Paramount Pictures' theatrical revenue sharply declined by 45% to $138 million, again largely due to the absence of a comparable tentpole release. Its most significant theatrical release during that quarter, "Scary Movie," grossed $108 million domestically and $231 million worldwide.

Currently, Paramount is not consistently producing the billion-dollar box office smashes that are vital for drawing large audiences and generating substantial revenue. The studio lacks titles that rival the projected 2026 successes of competitors, such as Disney-Pixar’s "Toy Story 5," Universal’s "The Odyssey" by Christopher Nolan, Sony’s "Spider-Man: Brand New Day," or Lionsgate’s "Michael." While Warner's "Dune 3" in December 2026 has billion-dollar potential, it would only be part of a Paramount-WBD lineup if the merger concludes before then. Smaller releases, such as the 3D concert film "Billie Eilish: Hit Me Hard and Soft," despite receiving rave reviews and grossing $9.9 million domestically, underscore that a collection of sub-$10 million films will not fundamentally alter the financial landscape for movie theaters or Paramount.